The myofascial component of the pain in the painful shoulder of the hemiplegic patient

Detalhes bibliográficos
Autor(a) principal: Liporaci, Felipe Martins
Data de Publicação: 2019
Outros Autores: Mourani, Márcio Massaro, Riberto, Marcelo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/157986
Resumo: OBJECTIVES: Poststroke shoulder pain occurs very frequently and compromises function and quality of life. Because treatment depends on a multidisciplinary approach, it is desirable to optimize effectiveness. Myofascial pain syndrome is defined by the presence of trigger points that can also be found in spastic stroke patients. The aim of this study was to evaluate the frequency of myofascial pain in the shoulder girdle muscles in patients with poststroke shoulder pain and to document the clinical and functional results obtained with specific treatment for this condition. METHODS: Spastic stroke hemiplegic patients undergoing rehabilitation at the Rehabilitation Center of the Hospital das Clı´nicas of the Ribeira˜o Preto Medical School of the University of Sa˜o Paulo were evaluated regarding the intensity and characteristics of shoulder pain, previous therapeutic interventions, shoulder goniometry and the presence of trigger points. Patients underwent trigger point blockade by intramuscular infiltration of 1% lidocaine. The evaluation and treatment procedures were repeated in the subsequent 3 weeks as long as the pain intensity was greater than 5 on a visual analog scale (VAS). In the fourth week, the evaluation procedures were repeated. Patients who were in a multiprofessional rehabilitation program were instructed to continue the treatment, and the others received complementary therapeutic advice if necessary to initiate it. The evaluations were performed at 0, 1, and 3 weeks and after 4 months. RESULTS: Twenty-one patients (13 men; age=67.8±10.2 years; right hemiparesis: 11) participated in the study, and there was a reduction in pain assessed by VAS from baseline (7.6±2.7) to the first week (5.8±3.6; po0.05) through the end of the third week (5.2±3.5; po0.05), but not at the end of four months (6.6±2.9; p=0.11). Good responders had significantly lower pain levels after the third week and presented with a larger range of motion for passive abduction by the end of 4 months. These results demonstrate that the myofascial component of pain should be considered in poststroke shoulder pain and that its treatment may be a pathway for the rapid and long-lasting relief of symptoms. CONCLUSION: Trigger point blockade with lidocaine can reduce pain perception in spastic hemiplegic shoulder in as much as 50% of stroke survivors for four months.
id USP-19_1f95885de7219a9ee6c3596b653fb953
oai_identifier_str oai:revistas.usp.br:article/157986
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling The myofascial component of the pain in the painful shoulder of the hemiplegic patientPainful ShoulderHemiplegiaTreatmentMyofascial Pain SyndromePainFunctioningOBJECTIVES: Poststroke shoulder pain occurs very frequently and compromises function and quality of life. Because treatment depends on a multidisciplinary approach, it is desirable to optimize effectiveness. Myofascial pain syndrome is defined by the presence of trigger points that can also be found in spastic stroke patients. The aim of this study was to evaluate the frequency of myofascial pain in the shoulder girdle muscles in patients with poststroke shoulder pain and to document the clinical and functional results obtained with specific treatment for this condition. METHODS: Spastic stroke hemiplegic patients undergoing rehabilitation at the Rehabilitation Center of the Hospital das Clı´nicas of the Ribeira˜o Preto Medical School of the University of Sa˜o Paulo were evaluated regarding the intensity and characteristics of shoulder pain, previous therapeutic interventions, shoulder goniometry and the presence of trigger points. Patients underwent trigger point blockade by intramuscular infiltration of 1% lidocaine. The evaluation and treatment procedures were repeated in the subsequent 3 weeks as long as the pain intensity was greater than 5 on a visual analog scale (VAS). In the fourth week, the evaluation procedures were repeated. Patients who were in a multiprofessional rehabilitation program were instructed to continue the treatment, and the others received complementary therapeutic advice if necessary to initiate it. The evaluations were performed at 0, 1, and 3 weeks and after 4 months. RESULTS: Twenty-one patients (13 men; age=67.8±10.2 years; right hemiparesis: 11) participated in the study, and there was a reduction in pain assessed by VAS from baseline (7.6±2.7) to the first week (5.8±3.6; po0.05) through the end of the third week (5.2±3.5; po0.05), but not at the end of four months (6.6±2.9; p=0.11). Good responders had significantly lower pain levels after the third week and presented with a larger range of motion for passive abduction by the end of 4 months. These results demonstrate that the myofascial component of pain should be considered in poststroke shoulder pain and that its treatment may be a pathway for the rapid and long-lasting relief of symptoms. CONCLUSION: Trigger point blockade with lidocaine can reduce pain perception in spastic hemiplegic shoulder in as much as 50% of stroke survivors for four months.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-05-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/15798610.6061/clinics/2019/e905Clinics; Vol. 74 (2019); e905Clinics; v. 74 (2019); e905Clinics; Vol. 74 (2019); e9051980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/157986/153249https://www.revistas.usp.br/clinics/article/view/157986/153595Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessLiporaci, Felipe MartinsMourani, Márcio MassaroRiberto, Marcelo2019-05-24T13:16:00Zoai:revistas.usp.br:article/157986Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-24T13:16Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv The myofascial component of the pain in the painful shoulder of the hemiplegic patient
title The myofascial component of the pain in the painful shoulder of the hemiplegic patient
spellingShingle The myofascial component of the pain in the painful shoulder of the hemiplegic patient
Liporaci, Felipe Martins
Painful Shoulder
Hemiplegia
Treatment
Myofascial Pain Syndrome
Pain
Functioning
title_short The myofascial component of the pain in the painful shoulder of the hemiplegic patient
title_full The myofascial component of the pain in the painful shoulder of the hemiplegic patient
title_fullStr The myofascial component of the pain in the painful shoulder of the hemiplegic patient
title_full_unstemmed The myofascial component of the pain in the painful shoulder of the hemiplegic patient
title_sort The myofascial component of the pain in the painful shoulder of the hemiplegic patient
author Liporaci, Felipe Martins
author_facet Liporaci, Felipe Martins
Mourani, Márcio Massaro
Riberto, Marcelo
author_role author
author2 Mourani, Márcio Massaro
Riberto, Marcelo
author2_role author
author
dc.contributor.author.fl_str_mv Liporaci, Felipe Martins
Mourani, Márcio Massaro
Riberto, Marcelo
dc.subject.por.fl_str_mv Painful Shoulder
Hemiplegia
Treatment
Myofascial Pain Syndrome
Pain
Functioning
topic Painful Shoulder
Hemiplegia
Treatment
Myofascial Pain Syndrome
Pain
Functioning
description OBJECTIVES: Poststroke shoulder pain occurs very frequently and compromises function and quality of life. Because treatment depends on a multidisciplinary approach, it is desirable to optimize effectiveness. Myofascial pain syndrome is defined by the presence of trigger points that can also be found in spastic stroke patients. The aim of this study was to evaluate the frequency of myofascial pain in the shoulder girdle muscles in patients with poststroke shoulder pain and to document the clinical and functional results obtained with specific treatment for this condition. METHODS: Spastic stroke hemiplegic patients undergoing rehabilitation at the Rehabilitation Center of the Hospital das Clı´nicas of the Ribeira˜o Preto Medical School of the University of Sa˜o Paulo were evaluated regarding the intensity and characteristics of shoulder pain, previous therapeutic interventions, shoulder goniometry and the presence of trigger points. Patients underwent trigger point blockade by intramuscular infiltration of 1% lidocaine. The evaluation and treatment procedures were repeated in the subsequent 3 weeks as long as the pain intensity was greater than 5 on a visual analog scale (VAS). In the fourth week, the evaluation procedures were repeated. Patients who were in a multiprofessional rehabilitation program were instructed to continue the treatment, and the others received complementary therapeutic advice if necessary to initiate it. The evaluations were performed at 0, 1, and 3 weeks and after 4 months. RESULTS: Twenty-one patients (13 men; age=67.8±10.2 years; right hemiparesis: 11) participated in the study, and there was a reduction in pain assessed by VAS from baseline (7.6±2.7) to the first week (5.8±3.6; po0.05) through the end of the third week (5.2±3.5; po0.05), but not at the end of four months (6.6±2.9; p=0.11). Good responders had significantly lower pain levels after the third week and presented with a larger range of motion for passive abduction by the end of 4 months. These results demonstrate that the myofascial component of pain should be considered in poststroke shoulder pain and that its treatment may be a pathway for the rapid and long-lasting relief of symptoms. CONCLUSION: Trigger point blockade with lidocaine can reduce pain perception in spastic hemiplegic shoulder in as much as 50% of stroke survivors for four months.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/157986
10.6061/clinics/2019/e905
url https://www.revistas.usp.br/clinics/article/view/157986
identifier_str_mv 10.6061/clinics/2019/e905
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/157986/153249
https://www.revistas.usp.br/clinics/article/view/157986/153595
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 74 (2019); e905
Clinics; v. 74 (2019); e905
Clinics; Vol. 74 (2019); e905
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222764144001024